Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1

In clinical trials recombinant-modified vaccinia virus Ankara expressing the Mycobacterium tuberculosis antigen 85A (MVA85A) induces approximately 10 times more effector T cells than any other recombinant MVA vaccine. We have found that in BCG primed subjects MVA85A vaccination reduces transforming...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fletcher, Helen A., Pathan, Ansar A., Berthoud, Tamara K., Dunachie, Susanna J., Whelan, Kathryn T., Alder, Nicola C., Sander, Clare R., Hill, Adrian V.S., McShane, Helen
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier Science 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2631167/
https://ncbi.nlm.nih.gov/pubmed/18682270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.07.040
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares